Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2007
10/17/2007CN101053607A Blood-nourishing and cephalocathartic micropills and its preparation technology
10/17/2007CN101053606A External applied stop smoking massage liquid and its preparation technology
10/17/2007CN101053567A Acetylcholinesterase inhibitor, its preparation method and application
10/17/2007CN101053564A Medicinal composition for anxiolytic and pain-alleviating
10/17/2007CN101053550A Rhizoma Gastrodiae nasal gel preparation
10/17/2007CN101053434A Clearing away heart-fire detoxification beverage
10/17/2007CN101053433A Mind-easing sedative beverage
10/17/2007CN101053398A Anthypnotic jasmine granule
10/17/2007CN100343258C Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines
10/17/2007CN100343256C Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists
10/17/2007CN100343254C Pyrrolopyrimidine derivatives
10/17/2007CN100342912C Sustained release composition for oral administration of drugs
10/17/2007CN100342859C Method for preparing formulation containing Indianmulberry extract
10/17/2007CN100342857C Ginseng pearl drpo pills and preparation process thereof
10/16/2007US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/16/2007US7282516 CB1, cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders
10/16/2007US7282513 Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase
10/16/2007US7282511 Isatine derivatives with neurotrophic activity
10/16/2007US7282510 neurotrophic N-glyoxyl-prolyl ester compounds e.g. (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidine carboxylic acid; non-immunosuppressive; side effect reduction; neurodegenerative diseases
10/16/2007US7282508 Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives and their use as selective non-peptide delta opioid agonists
10/16/2007US7282504 Kinase inhibitors
10/16/2007US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide
10/16/2007US7282501 Drugs for treatment of Syndrome X, diabetes, hypoglycemic agents, antilipemic agents, arteriosclerosis and cardiovascular agents
10/16/2007US7282500 Nitrogen compounds such as 4-(1-Hydroxyimino-indan-5-yl)-5-pyridin-4-yl-1H-imidazole-2-carboxylic Acid (2-morpholin-4-yl-ethyl)-amide, used as anticarcinogenic agents and for prophylaxis of brain disorders
10/16/2007US7282498 Substituted fused pyrroleoximes and fused pyrazoleoximes
10/16/2007US7282496 Rheumatic diseases; bone disorders; Aids; antiinflammatory agents
10/16/2007US7282494 Heteroaryl diazacycloalkanes, their preparation and use
10/16/2007US7282490 Osteopontin-related compositions and methods
10/16/2007US7282481 Improved thermostability, acid resistance, alkali resistance, resistance to proteolytic enzymes, and DNA synthesis promoting activity
10/16/2007US7282344 Also mutated GABAA receptor subunits, polynucleotide sequences encoding mutated subunits, expression vectors comprising the mutated subunits, host cells capable of expressing the mutated subunits, drug screening methods, and chemical substances identified by the method; high throughput drug screening
10/16/2007CA2414018C 2-aminocarbonyl-9h-purine derivatives
10/16/2007CA2319275C Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
10/16/2007CA2256013C Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic
10/16/2007CA2214026C Pharmaceutical compositions comprising monoamine oxidase b inhibitors
10/16/2007CA2209229C Novel sulfamate compound containing n-substituted carbamoyl group and method for preparing the same
10/13/2007CA2584745A1 Use of imidazo(2,1-b) -1,3,4-thiadiazole-2-sulfonamide compounds to treat neuropathic pain
10/13/2007CA2566832A1 Cyclised alpha-conotoxin peptides
10/11/2007WO2007115071A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers
10/11/2007WO2007114838A1 Amylin and amylin agonists for treating psychiatric diseases and disorders
10/11/2007WO2007114791A1 Lactate and calcium containing pharmaceutical composition and uses thereof
10/11/2007WO2007114771A1 2-AMINOPYRIMIDIN-4-ONES AND THEIR USE FOR TREATING OR PREVENTING Aβ-RELATED PATHOLOGIES
10/11/2007WO2007114540A1 Methods for modulating the development of dopamine neuron by the dopamine d2 receptor and compositions thereof
10/11/2007WO2007114323A1 Aminopyrrolidine compound
10/11/2007WO2007114213A1 Substituted bicyclic cyclic derivative and use thereof
10/11/2007WO2007114013A1 Composition containing lignan compound
10/11/2007WO2007113885A2 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them
10/11/2007WO2007113371A1 Pharmaceutical composition and preparation method thereof
10/11/2007WO2007113309A2 Compounds which inhibit the glycine transporter and uses thereof
10/11/2007WO2007113289A1 Benzofuran compounds as ep1 receptor antagonists
10/11/2007WO2007113276A1 Novel bi-aryl amines
10/11/2007WO2007113260A1 Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors
10/11/2007WO2007113258A1 Azabicyclo [3. 1. o] hexane derivatives as modulators of dopamine d3 receptors
10/11/2007WO2007113232A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors
10/11/2007WO2007113172A2 Antibodies against amyloid-beta peptide
10/11/2007WO2007113153A1 Piperidine derivatives useful as serotonin transporter inhibitors and neurokinin-1 receptor antagonists
10/11/2007WO2007112986A1 Compositions, methods, and kits using adenosine and inosine in combination for diagnosis and treatment
10/11/2007WO2007112922A1 Trimeric, water-soluble aminopyrazole compounds having an effect against neurodegenerative diseases
10/11/2007WO2007112757A2 A process for concentration of a polypeptide
10/11/2007WO2007112574A1 Extended release composition of venlafaxine
10/11/2007WO2007112556A1 Suppression and treatment of neuropathic pain
10/11/2007WO2007096396A3 Methods for treating autoimmune or demyelinating diseases
10/11/2007WO2007095618A3 Benzo-fused heterocycle sulfamide derivatives for the treatment of migraine
10/11/2007WO2007095609A3 Use of benzo-heteroaryl sulfamide derivatives for the treatment of mania and bipolar disorder
10/11/2007WO2007089335A3 Multicyclic amino acid derivatives and methods of their use
10/11/2007WO2007071967A3 Substituted phenol derivatives as analgesics
10/11/2007WO2007071313A3 Combination of anticholinergics, glucocorticoids, beta2-ag0nists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases
10/11/2007WO2007016679A3 Combination immediate release controlled release levodopa and carbidopa dosage forms
10/11/2007US20070238862 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling
10/11/2007US20070238787 Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease
10/11/2007US20070238786 Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease
10/11/2007US20070238783 Beta-benzyloxyaspartate derivatives with amino group on benzene ring
10/11/2007US20070238776 Novel Pyrroles Having Hypolipidemic Hypocholesteremic Activities, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in Medicine
10/11/2007US20070238768 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/11/2007US20070238766 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/11/2007US20070238763 Urea derivatives as integrin a4 antagonists
10/11/2007US20070238759 Novel Polymorph V of Torasemide
10/11/2007US20070238757 Novel treatment
10/11/2007US20070238749 Alpha2delta ligands for the treatment of fibromyalgia and other disorders
10/11/2007US20070238741 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine
10/11/2007US20070238738 Crystalline ziprasidone HCI and processes for preparation thereof
10/11/2007US20070238735 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
10/11/2007US20070238693 Genetic modification of the lung as a portal for gene delivery
10/11/2007US20070238677 Pharmaceutical Composition Containing Hshrd3
10/11/2007US20070238171 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
10/11/2007US20070237836 Strontium compound for treatment of sub-dermal soft tissue pain
10/11/2007US20070237833 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
10/11/2007US20070237832 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
10/11/2007US20070237825 Reusable, nonbioadhesive, microporous hydrogel for hydrating and dehydrating dermatological surfaces prepared from hydroxyalkyl (meth)acrylate, a crosslinking agent, water, aliphatic alcohol (isopropanol), and a fibrous filler
10/11/2007US20070237823 Solid Pharmaceutical Form Comprising and Ltb4 Antagonist
10/11/2007US20070237751 Human Cord Blood as a Source of Neural Tissue Repair of the Brain and Spinal Cord
10/11/2007DE60022050C5 Metabotrope glutamatrezeptorantagonisten zur behandlung von krankheiten des zentralen nervensystems Metabotropic glutamate receptor antagonists for treating diseases of the central nervous system
10/11/2007DE19701619B4 Verwendung von Pramipexol zur Behandlung des restless legs syndroms Use of pramipexole in the treatment of restless legs syndrome
10/11/2007DE102006015734A1 Kombinationspräparate aus Modafinil, Ritalin und Topiramat und deren Derivaten zur Behandlung von Kokainabhängigkeit und/oder Impulskontrollstörung Combination preparations of Modafinil, Ritalin and topiramate and its derivatives for the treatment of cocaine dependence and / or impulse control disorder
10/11/2007DE102006015733A1 Use of buprenorphine compounds to treat emotionally unstable personality disorder, alcohol dependence or multiple substance dependence
10/11/2007DE102006015140A1 Heterozyklische Verbindungen mit Wirkung gegen neurodegenerative Erkrankungen Heterocyclic compounds with activity against neurodegenerative diseases
10/11/2007CA2648652A1 Compounds for diseases and disorders
10/11/2007CA2648598A1 Lactate and calcium containing pharmaceutical composition and uses thereof
10/11/2007CA2648087A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors
10/11/2007CA2648065A1 Piperidine derivatives useful as serotonin transporter inhibitors and neurokinin-1 receptor antagonists
10/11/2007CA2648033A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers
1 ... 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 ... 1833